37 CFR § 1.765 — Duty of disclosure in patent term extension (MPEP Coverage Index) – BlueIron IP

37 CFR § 1.765 Duty of disclosure in patent term extension

Source: Patent Rule (37 CFR)BlueIron Update:

This page consolidates MPEP guidance interpreting 37 CFR § 1.765, including 25 rules from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.

Summary

This section details the duty of candor and good faith towards the USPTO, HHS Secretary, and USDA Secretary in patent term extension proceedings. It outlines the obligations of patent owners, attorneys, and agents to disclose material information accurately and timely.

What this section covers

  • Defines the duty of candor and good faith towards the USPTO, HHS Secretary, and USDA Secretary.
  • Provides guidance on the obligations of patent owners, attorneys, and agents in patent term extension proceedings.

Key obligations

  • Requires timely and accurate disclosure of material information.
  • Ensures attorneys and agents comply with this duty on behalf of their clients.
  • Sanctions for failure to comply include denial of patent term extension.

Practice notes

  • Maintain detailed records of communications and disclosures related to patent term extension.
  • Avoid making false or misleading statements in patent term extension proceedings to prevent potential sanctions.

Related Provisions

Based on MPEP Last Modified: 10/30/2024 08:50:22